Pfister, Sophia Xiao
Ashworth, Alan
Article History
First Online: 10 March 2017
Competing interests
: S.X.P. declares no competing interests. A.A. has patents on the use of PARP inhibitors held jointly with AstraZeneca and has benefitted financially (and may do so in the future) through the ICR Rewards to Inventors Scheme. A.A. is also a co-founder of Tango Therapeutics.